Carregant...
Shifting practice in definitive chemoradiation for localized esophageal cancer
BACKGROUND: The efficacy of carboplatin–paclitaxel in the trimodality setting was demonstrated in the cross trial. Because of better tolerance, that regimen has been adopted as an alternative for patients receiving definitive chemoradiation (dcrt). The purpose of our study was to compare outcomes in...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659162/ https://ncbi.nlm.nih.gov/pubmed/29089808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3677 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|